Home > Insider Trading > Filing (0001415889-23-012146)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
855654	Immunogen Inc.	IMGN	Pharmaceutical Preparations (2834)	042726691

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1814150	Ann Stacy Coen	C/O Immunogen, Inc. 830 Winter Street Waltham MA 02451	Svp & Chief Business Officer	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-08-09	100,210	$4.92	111,170	No	4	M	Direct
Common Stock	Disposition	2023-08-09	100,210	$14.20	10,960	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2023-08-09	100,210	$0.00	100,210	$4.92

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
75,209	2021-06-01	2030-06-01	No	4	M	Direct

Footnotes

The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.97 to $14.46, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within these ranges.
Exercisable as to 25% on the first year anniversary of the grant and 6.25% quarterly for the subsequent three years.